WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2016093515) COMPOSITION FOR ACTIVATING LONGEVITY GENE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2016/093515    International Application No.:    PCT/KR2015/012773
Publication Date: 16.06.2016 International Filing Date: 26.11.2015
IPC:
A61K 31/353 (2006.01), A61K 8/49 (2006.01), A61P 35/00 (2006.01), A61Q 19/08 (2006.01), A61P 3/10 (2006.01), A61Q 19/00 (2006.01), A61P 19/10 (2006.01), A61P 9/10 (2006.01), A61P 25/28 (2006.01)
Applicants: AMOREPACIFIC CORPORATION [KR/KR]; 106, Hangang-daero, Yongsan-gu, Seoul 140-777 (KR)
Inventors: KANG, Hyun Seo; (KR).
KIM, Hyoung June; (KR).
YOO, Se Jin; (KR).
KIM, Ji Hyun; (KR)
Agent: KIM, Sun-young; (KR)
Priority Data:
10-2014-0175698 09.12.2014 KR
10-2014-0175699 09.12.2014 KR
10-2014-0175700 09.12.2014 KR
10-2014-0175701 09.12.2014 KR
10-2014-0175702 09.12.2014 KR
Title (EN) COMPOSITION FOR ACTIVATING LONGEVITY GENE
(FR) COMPOSITION POUR ACTIVER UN GÈNE DE LONGÉVITÉ
(KO) 장수 유전자 활성화용 조성물
Abstract: front page image
(EN)Disclosed in the present specification is a composition for activating any one or more genes of an XPD gene, a Klotho gene, a Sirt-1 gene, an ERCC8 gene and a FoxO3 gene, the composition containing catechin comprising a methyl group, a salt thereof, a prodrug thereof, a hydrate thereof, a solvate thereof or an isomer thereof as an active ingredient. In one aspect, the technology disclosed in the present specification activates any one or more genes of an XPD gene, a Klotho gene, a Sirt-1 gene, an ERCC8 gene and a FoxO3 gene, and thus has an effect of providing a pharmaceutical composition, a cosmetic composition or a food composition useful for diseases associated with the genes, anti-aging, and skin improvement.
(FR)La présente invention concerne une composition destinée à activer l'un quelconque ou plusieurs gènes parmi un gène XPD, un gène Klotho, un gène Sirt-1, un gène ERCC8 et un gène FoxO3, la composition contenant de la catéchine comprenant un groupe méthyle, un sel de celle-ci, un promédicament de celle-ci, un hydrate de celle-ci, un solvate de celle-ci ou un isomère de celle-ci en tant que principe actif. Sous un aspect, la technologie décrite dans la présente description active l'un quelconque ou plusieurs gènes parmi un gène XPD, un gène Klotho, un gène Sirt-1, un gène ERCC8 et un gène FoxO3. Elle permet ainsi d'obtenir une composition pharmaceutique, une composition cosmétique ou une composition alimentaire utiles pour des maladies associées aux gènes, pour la lutte contre le vieillissement et pour l'amélioration de la peau.
(KO)본 명세서에는 메틸기를 포함하는 카테킨, 이의 염, 이의 프로드럭, 이의 수화물, 이의 용매화물 또는 이의 이성질체를 유효성분으로 함유하는 XPD 유전자, Klotho 유전자, Sirt-1 유전자, ERCC8 유전자 및 FoxO3 유전자 중 어느 하나 이상의 유전자 활성화용 조성물이 개시된다. 일 측면에서, 본 명세서에 개시된 기술은 XPD 유전자, Klotho 유전자, Sirt-1 유전자, ERCC8 유전자 및 FoxO3 유전자 중 어느 하나 이상의 유전자를 활성화함으로써 상기 유전자들과 관련된 질환, 항노화, 피부 개선에 유용한 약학 조성물, 화장료 조성물 또는 식품 조성물을 제공하는 효과가 있다.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: Korean (KO)
Filing Language: Korean (KO)